Central neuronal-glial mechanisms and neurohumoral activation in hypertension
高血压的中枢神经元神经胶质机制和神经体液激活
基本信息
- 批准号:8477277
- 负责人:
- 金额:$ 35.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-06-01 至 2016-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAngiotensin IIAnimal ModelAstrocytesBrainCardiovascular DiseasesCardiovascular systemCell NucleusCoupledCouplingDataDevelopmentEquilibriumGenerationsGlutamatesHomeostasisHypertensionHypothalamic structureIn VitroKnowledgeLinkMaintenanceMediatingMorbidity - disease rateN-Methyl-D-Aspartate ReceptorsN-MethylaspartateNeuraxisNeurobiologyNeuronsNeurosecretory SystemsPatientsPlayPreventionPrincipal InvestigatorPropertyPublic HealthRattusRelative (related person)RoleSeriesSignal TransductionSourceSympathetic Nervous SystemSynapsesTestingTherapeuticWorkhypertension treatmentin vivointerdisciplinary approachkidney vascular structuremortalitynovelparaventricular nucleusreceptor functionresponsetreatment strategy
项目摘要
DESCRIPTION (provided by applicant): While coordinated activities of the sympathetic and neuroendocrine systems are essential for proper maintenance of cardiovascular (CV) homeostasis, sustained sympathohumoral activation is highly detrimental, contributing to CV disorders including hypertension. Thus, elucidating mechanisms regulating sympathohumoral activation is critical for the prevention and more efficient treatment of hypertension. The hypothalamic paraventricular (PVN) nucleus plays pivotal roles in the generation of sympathohumoral responses. Neuronal activity within this nucleus is controlled by a balance between intrinsic properties and extrinsic synaptic inputs. In recent studies, we showed that the A-type K+ current (IA) inhibits PVN firing activity, and that blunted IA function contributes to enhanced neuronal activity in hypertension. Another major pathogenic factor in hypertension is increased glutamate NMDA receptor function. However, whether these two distinct mechanisms are functionally and causally coupled, is at present unknown. Using a multidisciplinary approach combining in vitro and in vivo studies, we obtained exciting preliminary data supporting a causal link between extrasynaptic NMDARs and IA in mediating increased neuronal activity and sympathoumoral activation in hypertension. Moreover we found astrocytes to be pivotal players influencing the efficacy of the eNMDAR-IA coupling. In this proposal, we will test the central hypothesis that over-activation of eNMDARs and its negative coupling to IA is a major contributing factor underlying increased neuronal activity and sympathohumoral activation in hypertension. The main objective of this application is to characterize the signaling mechanisms underlying the eNMDAR-IA coupling. Moreover, we aim to elucidate the relative contribution of (a) altered glial function and (b) intrinsic neuronal mechanisms to overactivation of the eNMDAR-IA coupling, and increased neuronal activity and sympathohumoral activation in hypertensive rats. Using a renovascular hypertensive animal model, we propose the following Specific Aims: Aim 1- To characterize the functional coupling between eNMDARs and IA; Aim 2- To determine if altered glial function contributes to enhanced eNMDAR-IA coupling in hypertensive rats; and Aim 3- To determine if altered neuronal mechanisms contribute to enhanced eNMDAR-IA coupling in hypertensive rats. We expect this work to expand our knowledge on basic neurobiological principles implicated in the generation of homeostatic neurohumoral responses. More importantly, we expect to identify key pathophysiological brain mechanisms contributing to maldaptive neurohumoral responses in hypertension. We hope our work will help in the development of novel and more efficient therapeutic strategies for the treatment of hypertensive conditions.
描述(由申请人提供):虽然交感神经和神经内分泌系统的协调活动对于适当维持心血管(CV)稳态至关重要,但持续的交感体液激活是非常有害的,会导致包括高血压在内的CV疾病。因此,阐明调节交感体液激活的机制对于预防和更有效地治疗高血压至关重要。下丘脑室旁核(PVN)在交感体液反应的产生中起关键作用。该核内的神经元活动由内在特性和外在突触输入之间的平衡控制。在最近的研究中,我们发现A型K+电流(IA)抑制PVN放电活动,并且IA功能的钝化有助于高血压时神经元活动的增强。高血压的另一个主要致病因素是谷氨酸NMDA受体功能增加。然而,这两种不同的机制是否在功能上和因果上耦合,目前尚不清楚。使用多学科的方法结合在体外和体内的研究,我们获得了令人兴奋的初步数据,支持突触外NMDAR和IA之间的因果关系,在介导增加的神经元活动和交感神经激活高血压。此外,我们发现星形胶质细胞是影响eNMDAR-IA偶联的功效的关键参与者。在这项提议中,我们将测试的核心假设,过度激活eNMDAR和其负耦合IA是一个主要的因素,增加神经元活动和交感体液激活高血压。本申请的主要目的是表征eNMDAR-IA偶联背后的信号传导机制。此外,我们的目的是阐明相对贡献(a)改变胶质细胞功能和(B)内在神经元机制过度激活的eNMDAR-IA耦合,并增加神经元活动和交感体液激活高血压大鼠。 使用肾血管性高血压动物模型,我们提出以下具体目的:目的1-表征eNMDARs和IA之间的功能偶联;目的2-确定是否改变的胶质细胞功能有助于增强高血压大鼠的eNMDAR-IA偶联;目的3-确定是否改变的神经元机制有助于增强高血压大鼠的eNMDAR-IA偶联。我们希望这项工作,以扩大我们的基本神经生物学原理的知识,涉及到产生的稳态神经体液反应。更重要的是,我们希望确定关键的病理生理脑机制,有助于适应性神经体液反应在高血压。我们希望我们的工作将有助于开发新的和更有效的治疗高血压疾病的治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Javier E Stern其他文献
Javier E Stern的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Javier E Stern', 18)}}的其他基金
Novel SCN-OVLT portal system: Dissecting Anatomical and Functional Properties
新型 SCN-OVLT 门户系统:剖析解剖和功能特性
- 批准号:
10754088 - 财政年份:2023
- 资助金额:
$ 35.7万 - 项目类别:
DENDRITIC RELEASE OF NEUROPEPTIDES: ROLE IN BODILY HOMEOSTASIS
神经肽的树突释放:在身体稳态中的作用
- 批准号:
9618919 - 财政年份:2018
- 资助金额:
$ 35.7万 - 项目类别:
DENDRITIC RELEASE OF NEUROPEPTIDES: ROLE IN BODILY HOMEOSTASIS
神经肽的树突释放:在身体稳态中的作用
- 批准号:
9769162 - 财政年份:2018
- 资助金额:
$ 35.7万 - 项目类别:
Central neuronal-glial mechanisms and neurohumoral activation in hypertension
高血压的中枢神经元神经胶质机制和神经体液激活
- 批准号:
8373050 - 财政年份:2012
- 资助金额:
$ 35.7万 - 项目类别:
Central neuronal-glial mechanisms and neurohumoral activation in hypertension
高血压的中枢神经元神经胶质机制和神经体液激活
- 批准号:
8669816 - 财政年份:2012
- 资助金额:
$ 35.7万 - 项目类别:
CO regulation of hypothalamic neuronal activity in health and disease states
健康和疾病状态下丘脑神经元活动的 CO 调节
- 批准号:
8458529 - 财政年份:2012
- 资助金额:
$ 35.7万 - 项目类别:
CO regulation of hypothalamic neuronal activity in health and disease states
健康和疾病状态下丘脑神经元活动的 CO 调节
- 批准号:
8282375 - 财政年份:2012
- 资助金额:
$ 35.7万 - 项目类别:
CENTRAL NEURONAL-GLIAL MECHANISMS AND NEUROHUMORAL ACTIVATION IN HYPERTENSION
高血压的中枢神经元神经胶质机制和神经体液激活
- 批准号:
9618915 - 财政年份:2012
- 资助金额:
$ 35.7万 - 项目类别:
Altered CNS intercellular signaling mechanisms in cardiovascular disease
心血管疾病中中枢神经系统细胞间信号传导机制的改变
- 批准号:
8011516 - 财政年份:2008
- 资助金额:
$ 35.7万 - 项目类别:
Altered CNS Intercellular Signaling Mechanisms in Cardiovascular Disease
心血管疾病中中枢神经系统细胞间信号传导机制的改变
- 批准号:
9084606 - 财政年份:2008
- 资助金额:
$ 35.7万 - 项目类别:
相似海外基金
Early endothelial function activation by angiotensin II receptor blockers prevents vascular damage in a model of diabetes
血管紧张素 II 受体阻滞剂早期激活内皮功能可预防糖尿病模型中的血管损伤
- 批准号:
493141 - 财政年份:2023
- 资助金额:
$ 35.7万 - 项目类别:
Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aorta
血管紧张素II受体阻滞剂对主动脉缩窄修复患者心血管重塑的临床疗效及作用机制
- 批准号:
10734120 - 财政年份:2023
- 资助金额:
$ 35.7万 - 项目类别:
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
- 批准号:
10707997 - 财政年份:2022
- 资助金额:
$ 35.7万 - 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
- 批准号:
RGPIN-2016-04414 - 财政年份:2022
- 资助金额:
$ 35.7万 - 项目类别:
Discovery Grants Program - Individual
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
- 批准号:
10555926 - 财政年份:2022
- 资助金额:
$ 35.7万 - 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
- 批准号:
RGPIN-2016-04414 - 财政年份:2021
- 资助金额:
$ 35.7万 - 项目类别:
Discovery Grants Program - Individual
Targeting cancer-associated fibroblasts and tumour hypoxia with angiotensin II receptor blockers
使用血管紧张素 II 受体阻滞剂靶向癌症相关成纤维细胞和肿瘤缺氧
- 批准号:
445961 - 财政年份:2021
- 资助金额:
$ 35.7万 - 项目类别:
Operating Grants
Intratubular Angiotensin II and AT1a Receptors in The Proximal Tubules: Roles in Hypertension and Kidney Injury
近曲小管中的管内血管紧张素 II 和 AT1a 受体:在高血压和肾损伤中的作用
- 批准号:
10164776 - 财政年份:2020
- 资助金额:
$ 35.7万 - 项目类别:
Novel Roles of Mitochondrial Angiotensin II in The Proximal Tubule of The Kidney
线粒体血管紧张素 II 在肾近端小管中的新作用
- 批准号:
10251271 - 财政年份:2020
- 资助金额:
$ 35.7万 - 项目类别:
Protection and organ injury by angiotensin II treatment for septic shock
血管紧张素II治疗感染性休克的保护作用和器官损伤
- 批准号:
20K09284 - 财政年份:2020
- 资助金额:
$ 35.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)